Angina sufferers find significant relief with noninvasive technique
...ieve improved blood flow." The research team plans next to undertake studies to clarify if and how muchheart blood flow is improved by the EECP technique. Lead author on the journal report is Rohit R. Arora, MD, assistant professor ofmedicine at Columbia University. Co-authors, along with Chou and Nesto, ...New outpatient surgery is helping women with stress incontinence
...nce are constantly on guard,never knowing when the next wet patch will appear. Exercises and medication are the first line of treatment. But if they fail,surgery may be best. Many procedures have been developed, but a new outpatientprocedure called TVT (tension-free vaginal tape) now is being tested on fe......e are fewer complications and patients go home the next morning. I have nodoubt that within the next five years, this will be the method of choice." In comparison, because of the larger incisions, grea......el for human biology," Miller said. Lee and Auchus next tested MPA on 3bHSDII (3-beta-HSD-2), the next step afterP450c17 in the cascade of enzymes essential to making human hormones. They foundthat MPA i......Medical Center. "CAMPATH may very well become the next newand promising monoclonal antibody therapy for patients with cancer. For our patients withCLL, CAMPATH may change the expectation from one of relentlessly progressive deterioration on palliative therapies to the hope of extended survival," said D...Hopkins study shows combined hormone therapy increases muscle, decreases fat in postmenopausal women
...for three monthsand estrogen plus androgen for the next four months. After four months on the combined medication, the women had an average 2 to 4percent reduction in body fat and an average 4 to 6 percent increase in musclemass. By contrast, estrogen alone yielded slight increases in both fat andmuscl...7,000 Pharmaceutical scientists to share latest drug developments and discoveries
...logy willlead the pharmaceutical sciences into the next century. "The plenary session promises to provide a glimpse into the future of drugtherapy and health care and a recap of the most significant advances made in thepharmaceutical sciences over the past century," said AAPS Annual Meeting ProgramChair ...Pennsylvania voters believe tobacco settlement funds should be used for cancer research
...proximately 12 billion dollars in damages over the next 25 years. How those funds are used has yet to be d...uture generations." It is projected that, over the next 10 years, 700,000 Pennsylvania residentswill be diagnosed with cancer and approximately 300,000 will......expected to increase to some $240 billion over the next 50 years as thepopulation ages, Arnaud said. "This is comparable to our current defense budget, and is an amount that ourcountry probably cannot afford," he said. "If bone loss can be restored, we canavoid much suffering and spare society this enorm...Immune system rebounds for some children with AIDS, finds UF study
...ns and their effects on theimmune system. Over the next year or so, we should begin to know the resultsof ...$192,000 grant tocontinue his research. During the next two years, he plans to compare thepotential for immune system reconstitution in children under 2, th......hunder, you are already within the range where the next groundflash may occur. N. Kitagawa of Central Ligh...ayas possible - at least 2 meters (7 ft). Standing next to tall isolated objectslike poles or towers makes you vulnerable to secondary discharges coming off...Pediatrician will work to cut sexually transmitted diseases
...heand his Add Health colleagues gather information next year on 20,000 U.S.residents between ages 18 and 25. Participants will be the same as those randomly selected and surveyed asadolescents in 1994and 1995. Results of the earlier work made national headlines in 1997 becausethey proved, among...Risk from getting pregnant too soon after a stillbirth
...ay be an advantage in waiting 12 months before the next conception." Women who conceived more than 12 mont...llbirth had a lower trait anxiety a year after the next birth. A key message from the BMJ paper is: "Women may need a year to mourn the lost child before be...Novel drug therapy tackles third 'pathway' causing congestive heart failure
...t to have theresults of these trials by the end of next year. It's hoped this willeventually lead to improved medications to treat congestive heart failure, whichcurrently affects over 4.5 Americans." Co-authors were Anita Deswal; Biykem Bozkurt; Yukihiro Seta; SemahatParilti-Eiswirth; F. Ann Hayes; and ...Unexpected target may unlock the door to fighting sepsis
...te hydrogen peroxide is suppressed." Ward says the next steps are for these findings to be verified in other modelsof sepsis and in other non-human animals. Clinically, he says, the first thingthat should be done is human trials that do not involve interventions. Thiswould include taking blood samples, lo......atic improvement right away that continuesover the next few months," Dr. Fontana explained. "By three to six months, theresults are typically as good as they will get. Most patients can assume ahigher level of function and become more active." Dr. Frischling whole-heartedly concurs. "I just went on a fish...Robotic technology to help Ohio State University heart surgeons
...ng the equipment inthe next year. University physicians joined officials fromIntuitive Surgery, Inc., manufacturer of the da Vinci Computer-Enhanced Surgical System, in announcing a ...Combination HIV vaccine induces diverse immune response
...stime, the data needed to consider moving into the next phase of testing isexpected to be available by late 2000.......ope that we may be able to protect manyof Africa's next generation from the ravages of AIDS," says Crispus Kiyonga,M.B.Ch.B., Uganda's Minister of Health. "We commend the collaborative effort ofour country's scientists, led by Professor Francis Mmiro from MakerereUniversity Faculty of Medicine, and their...NOVANTRONE application for multiple sclerosis granted priority review by FDA
...ill continue to work closely with the FDA over the next six months as theyevaluate these data." The results of the pivotal NOVANTRONE Phase III study showed thatNOVANTRONE had a statistically significant impact on reduction of relapse rateand delay in disability progression in patients with second...